The notices it replaced
- Reissues: RFA-CA-22-001 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Replaced by RFA-CA-24-008.
Who won it before
24 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,470,186 in first-year total cost, median $218,391.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-D (O1)]8
- Special Emphasis Panel[ZCA1 TCRB-Q (J1)]8
- Special Emphasis Panel[ZCA1 TCRB-5 (M1)]4
- Special Emphasis Panel[ZCA1 TCRB-D (M1)]4
Most frequent institutions
- STANFORD UNIVERSITY3
- BROAD INSTITUTE, INC.2
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- BOSTON COLLEGE1
- COLUMBIA UNIV NEW YORK MORNINGSIDE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Bioreactor for Manufacturing Chemotactically Competent Immune Cell Therapies1R61CA281785-01A1 | LIU, XIAOHE | SRI INTERNATIONAL, CA | $375,016 | ZCA1 |
| 2024 | New Chemical Tools for Covalent Drug Discovery1R61CA278449-01A1 | KIM, JUSTINMARTO, JARROD A. | DANA-FARBER CANCER INST, MA | $249,647 | ZCA1 |
| 2024 | A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle state1R61CA278458-01A1 | ROSTOMILY, ROBERT CST-PIERRE, FRANCOIS | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $240,484 | ZCA1 |
| 2024 | Multiplexed, Continuous Reporting of Gene Expression via CRISPR-mediated Transcriptional Activation1R61CA291201-01 | ISHIZUKA, JEFFREY J. | YALE UNIVERSITY, CT | $234,919 | ZCA1 |
| 2024 | A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications1R61CA287026-01 | HAAS, WILHELMSEQUIST, LECIA V. | MASSACHUSETTS GENERAL HOSPITAL, MA | $234,218 | ZCA1 |
| 2024 | Proximity epigenomics for context-specific analysis of complex chromatin features1R61CA278503-01A1 | OBERDOERFFER, PHILIPP | JOHNS HOPKINS UNIVERSITY, MD | $229,659 | ZCA1 |
| 2024 | Spatially resolved multi-omics sequencing of FFPE tissues at cellular level1R61CA287408-01A1 | DENG, YANXIANG | UNIVERSITY OF PENNSYLVANIA, PA | $227,906 | ZCA1 |
| 2024 | Quantitative analysis and manipulation of chromosome dynamics in cancer organoids1R61CA278518-01A1 | WITTMANN, TORSTEN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $226,505 | ZCA1 |
| 2024 | Development of A Directed Evolution Platform for RNA Methyltransferases.1R61CA291202-01 | NIU, JIAZHOU, HUIQING | BOSTON COLLEGE, MA | $217,388 | ZCA1 |
| 2024 | Tumor Metabolic Profiling by Multiplexed Single-Cell Lipid and mRNA Imaging1R61CA278450-01A1 | HEILSHORN, SARAH C | STANFORD UNIVERSITY, CA | $216,546 | ZCA1 |
| 2024 | Evolved Molecules that Destroy Cancer Relevant Proteins1R61CA291117-01 | BIONDI, ELISA | FOUNDATION FOR APPLIED MOLECULAR EVOLUTN, FL | $215,564 | ZCA1 |
| 2024 | Profiling and perturbing the inheritance of drug-induced metabolic states in cancer with Inheritance-Seq1R61CA278536-01A1 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC., MA | $207,092 | ZCA1 |
| 2023 | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis1R61CA278559-01 · under RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH, UT | $243,486 | ZCA1 |
| 2023 | Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries1R61CA281807-01 · under RFA-CA-22-001 | HACOHEN, NIR | BROAD INSTITUTE, INC., MA | $221,595 | ZCA1 |
| 2023 | High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes1R61CA278558-01 · under RFA-CA-22-001 | HARIADI, RIZAL FAJARYAN, HAO | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $220,193 | ZCA1 |
| 2023 | Integrated Imaging Tools for Intercellular Chemokine Signalling1R61CA281657-01 · under RFA-CA-22-001 | LUKER, GARY D | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $218,790 | ZCA1 |
| 2023 | Program the Immune System against RAS-driven Cancer1R61CA278398-01 · under RFA-CA-22-001 | GAO, XIAOJING JWINSLOW, MONTE MEIER | STANFORD UNIVERSITY, CA | $217,992 | ZCA1 |
| 2023 | Intersectional genetics-based biosensors for dormant cancer cells1R61CA278402-01 · under RFA-CA-22-001 | BRAVO-CORDERO, JOSE JAVIER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $217,772 | ZCA1 |
| 2023 | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer1R61CA278459-01 · under RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY, CA | $216,862 | ZCA1 |
| 2023 | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood1R61CA278531-01 · under RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $216,584 | ZCA1 |
| 2023 | Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell Carcinomas1R61CA281667-01 · under RFA-CA-22-001 | FERNANDEZ, FACUNDO MARTIN | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $215,136 | ZCA1 |
| 2023 | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.1R61CA281795-01 · under RFA-CA-22-001 | CAMPAGNOLA, PAUL JYESILKOY, FILIZ | UNIVERSITY OF WISCONSIN-MADISON, WI | $208,402 | ZCA1 |
| 2023 | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers1R61CA278445-01 · under RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $204,831 | ZCA1 |
| 2023 | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates1R61CA278452-01 · under RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | $193,599 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.